What is the optimal management of potentially resectable stage III-N2 NSCLC? Results of a fixed-effects network meta-analysis and economic modelling

INTRODUCTION: There is a critical need to understand the optimal treatment regimen in patients with potentially resectable stage III-N2 nonsmall cell lung cancer (NSCLC). METHODS: A systematic review of randomised controlled trials was carried out using a literature search including the CDSR, CENTRA...

Descripción completa

Detalles Bibliográficos
Autores principales: Evison, Matthew, Maconachie, Ross, Mercer, Toby, Daly, Caitlin H., Welton, Nicky J., Aslam, Shahzeena, West, Doug, Navani, Neal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2023
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068518/
https://www.ncbi.nlm.nih.gov/pubmed/37020838
http://dx.doi.org/10.1183/23120541.00299-2022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068518/
https://www.ncbi.nlm.nih.gov/pubmed/37020838
http://dx.doi.org/10.1183/23120541.00299-2022

Ejemplares similares